Cargando…
Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases
YB-1 (Y-box binding protein 1) is a multifunctional cold-shock protein that has been implicated in all hallmarks of cancer. Elevated YB-1 protein level was associated with poor prognosis in several types of cancers, including breast cancer (BC), where it is a marker of decreased overall survival (OS...
Autores principales: | Ferreira, A.R., Bettencourt, M., Alho, I., Costa, A.L., Sousa, A.R., Mansinho, A., Abreu, C., Pulido, C., Macedo, D., Vendrell, I., Pacheco, T.R., Costa, L., Casimiro, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294742/ https://www.ncbi.nlm.nih.gov/pubmed/28194325 http://dx.doi.org/10.1016/j.jbo.2017.01.002 |
Ejemplares similares
-
Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
por: Mansinho, André, et al.
Publicado: (2019) -
Bone metastasis risk factors in breast cancer
por: Pulido, Catarina, et al.
Publicado: (2017) -
The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases
por: Ferreira, Arlindo, et al.
Publicado: (2016) -
Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?
por: Casimiro, Sandra, et al.
Publicado: (2016) -
RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells
por: Casimiro, S., et al.
Publicado: (2013)